Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
ConclusionATB were associated with reduced clinical benefit from ICI in RCC and NSCLC. Modulatation of ATB-related dysbiosis and gut microbiota composition may be a strategy to improve clinical outcomes with ICI.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Pneumonia | Renal Cell Carcinoma | Urinary Tract Infections